Ontology highlight
ABSTRACT:
SUBMITTER: Dimisianos N
PROVIDER: S-EPMC4134814 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
Dimisianos Nikolaos N Rodi Maria M Kalavrizioti Dimitra D Georgiou Vasileios V Papathanasopoulos Panagiotis P Mouzaki Athanasia A
Multiple sclerosis international 20140722
Background. MS patients show a remarkable heterogeneity in their response to disease modifying treatments. Given the need for early treatment initiation and the diversity of available options, a predictive marker that indicates good or poor response to treatment is highly desirable. Objective. To find a biomarker for treatment response to IFNβ among pro- and anti-inflammatory cytokines. Materials and Methods. IFN-γ, TNF-α, IL-2, IL-4, IL-6, IL-10, IL-17A, and TGF-β1 levels were measured in serum ...[more]